Adams Diversified Equity Fund, Inc. Repligen Corp Transaction History

Adams Diversified Equity Fund, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 28, 2019	SELL	$76.65 - $95.51 $130,305 - $162,367	-1,700 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$54.2 - $85.95 $54,200 - $85,950	-1,000 Reduced 37.04%	1,700 $146,000
Q1 2019 Apr 26, 2019	BUY	$49.45 - $62.8 $133,515 - $169,560	2,700 New	2,700 $160,000
Q1 2018 Apr 27, 2018	SELL	$30.92 - $37.27 $405,052 - $488,237	-13,100 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$32.53 - $38.92 $123,614 - $147,896	-3,800 Reduced 22.49%	13,100 $475,000
Q3 2017 Oct 30, 2017	BUY	$36.98 - $46.06 $624,962 - $778,414	16,900	16,900 $648,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.